Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

<p>Demographics and Baseline Characteristics</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Cloud P. Paweletz (14960112) (author)
Diğer Yazarlar:	Grace A. Heavey (16495683) (author), Yanan Kuang (16495686) (author), Emily Durlacher (16495689) (author), Thian Kheoh (16495692) (author), Richard C. Chao (16495695) (author), Alexander I. Spira (16495698) (author), Konstantinos Leventakos (16495701) (author), Melissa L. Johnson (16019536) (author), Sai-Hong Ignatius Ou (15023025) (author), Gregory J. Riely (14961725) (author), Kenna Anderes (15123501) (author), Wenjing Yang (16495704) (author), James G. Christensen (15123507) (author), Pasi A. Jänne (14954872) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Clinical Research and Trials Methods and Technology Imaging Liquid Biopsy Precision Medicine
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller